Long Covid Antibody Spectrum Test (AMVAIS)

The Attomarker Multi-Variant Antibody Immunity Spectrum (AMVAIS) test helps us to get one step closer to precision medicine in Long Covid treatments – in this case especially in the area of antiviral therapy. Antibodies are a vital part of our immune systems. When analysing patient antibody responses across a range of COVID variants, it is evident that individual immunity and hence how vulnerable a person is, noticeably varies. In case of the AMVAIS test these individual responses are called immunity endotypes. 

We expect to return your results within 2 weeks upon receipt of the sample. You will receive: an Antibody Spectrum and Laboratory Report.

Prof Andrew Shaw about Antibody immune profiling in Long Covid (Video source: LCCWYCD)

 *Service  provided by Attomarker